Regeneron Pharmaceuticals: Q1 Earnings Insights

Regeneron Pharmaceuticals REGN reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Regeneron Pharmaceuticals beat estimated earnings by 14.44%, reporting an EPS of $11.49 versus an estimate of $10.04.

Revenue was up $436.00 million from the same period last year.

Last quarter the company beat on EPS by $5.61 which was followed by a 0.37% increase in the share price the next day.

Here's a look at Regeneron Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	18.11	9.49	17.69	9.03
EPS Actual	23.72	15.37	25.80	9.89
Revenue Estimate	4.47B	2.79B	3.89B	2.56B
Revenue Actual	4.95B	3.45B	5.14B	2.53B

To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar